A Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen CEP of the European Pharmacopoeia monograph is often referred to as a Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen Certificate of Suitability (COS). The purpose of a Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen to their clients by showing that a Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen CEP has been issued for it. The manufacturer submits a Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen CEP holder for the record. Additionally, the data presented in the Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen DMF.
A Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, Clafen suppliers with CEP (COS) on PharmaCompass.